Technology

ADDF invest in BrainScope for Alzheimer’s prediction biomarker

BrainScope has announced an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in an ongoing Series B round to pursue…

Drug manufacturing automation key as populations age, says Lotte Biologics CEO 

Widespread adoption of automation in drug manufacturing is key to addressing the healthcare issues that affect ageing populations, said Lotte…

Alexion and Verge enter AI-powered drug discovery deal

Alexion, AstraZeneca Rare Disease has entered a multi-target partnership agreement with Verge Genomics to detect new drug targets for rare…

Physician comfort level with sales reps using AI for sales messaging is growing

The increasing workload of healthcare professionals (HCPs) limits the amount of time they can dedicate to sales representatives. This means…

Bayer signs commercialisation deal for Mahana’s digital therapeutics range

Mahana Therapeutics has announced it has entered a distribution and marketing partnership with the Consumer Health division of Bayer, opening…

Qualifyze secures funds to transform pharma supply chain compliance

German compliance company Qualifyze has secured $12m in a financing round to improve supply chain compliance in the pharmaceutical sector using technological…

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

Artificial intelligence (AI)-led drug development company Genesis Therapeutics has raised $200m in Series B financing. Returning investor a16z Bio +…

AI is essential for the future of drug discovery and development

Artificial intelligence is everywhere. According to GlobalData forecasts, every segment of the AI market is expected to grow in the…

Artificial Intelligence related patent filings increased in the pharmaceutical industry in Q2 2023

The global pharmaceutical industry experienced a 52% rise in the number of artificial intelligence-related patent applications in Q2 2023 compared…

Future of Work related patent filings decreased in the pharmaceutical industry in Q2 2023

The global pharmaceutical industry experienced a 25% decline in the number of future of work-related patent applications in Q2 2023…